Gilead Sciences Announces Third-Quarter 2026 Results
Story updates
08:16:35 PM UTC
SquawkNews
Gilead Sciences reported third-quarter 2026 revenue of $8.3 billion, up 7% year over year, as product sales rose 13%. GAAP diluted EPS was $1.94, while non-GAAP diluted EPS increased to $2.55 from $2.47. The company raised its 2026 product sales outlook and revised its full-year diluted loss per sh…